The Europe medical thawing system market growth is anticipated to progress at a CAGR of 7.85% during the forecast period, 2022-2030, reaching a revenue of $111.87 million by 2030.

The market growth in Europe is attributed to the increasing need for medical thawing systems in blood banks and labs, wherein de-freezing is required for RBC, crystalloid infusion solution, and complete blood before transfusion. Also, technological advancements in automated thawing systems at the point of care settings and the rising demand for thawing methods for frozen plasma in varied surgical methods drive growth.

To know more about this report, request a free sample copy

The Europe medical thawing system market growth analysis includes the evaluation of Nordic Countries, Italy, Spain, the United Kingdom, Germany, France, and Rest of Europe. In the United Kingdom, the National Health Service (NHS) offers a free healthcare system that further enables healthcare access to the masses. Also, the UK government is set to increase the age limit to 55 for embryos, eggs, and sperm freezing under the new policy, as of September 2021. This is estimated to encourage more people to store their reproductive samples.

Further, the UK recorded 1516 deaths due to road accidents in 2020. Vehicular accidents require a constant blood supply, wherein thawing systems play an important role. As a result, the key growth drivers of the UK are efficient healthcare, increasing road accidents, and government initiatives to promote sample collection.

In France, vehicular accidents are one the major causes of death. The rising number of accidents and the resultant heavy blood loss require a blood transfusion. Additionally, the country has several established biotech and pharmaceutical companies like Cardinal Health, Pfizer, Novartis, Roche Diagnostics, etc., that make use of thawing systems in drug development. Besides, the parliament voted to extend in-vitro fertilization (IVF) rights to women in 2021. This is projected to boost embryo freezing. Such developments facilitate market growth in France.

In Spain, seventeen regional blood transfusion services offer blood components and services. Also, the biotechnology sector made significant investments in R&D in 2020, of which biotech companies accounted for 71%. In addition, it has the highest percentage of scientific papers in high-impact journals than any other country, alongside ranking ninth in scientific production in biotechnology. Accordingly, the country’s biotech industry is evaluated to offer growth opportunities.

The report scope of the Europe medical thawing system market includes end-user and sample type. The sample type is further sub-categorized into ovum, semen, embryo, and blood.

Blood comprises four main constituents, platelets, white blood cells, red blood cells, and plasma. It has varied functions that include oxygen and nutrient transportation to the tissues and lungs. These components are crucial for the vital metabolic functions of the human body. Additionally, blood is frozen in hospitals and blood banks to raise the shelf life. Besides, fresh frozen plasma (FFP) needs 45 minutes to thaw in a 37^o C water bath when placed in an additional plastic overbag.

Some of the prominent firms operating in the Europe medical thawing system market include Sarstedt AG & Co KG, KW Apparecchi Scientifici, Meissner, Sartorius AG, etc.

Sartorius AG offers lab products, services, and bioprocess solutions globally. It aids in the manufacture and development of biotech medications and vaccines. The company’s bioprocess solutions segment is engaged in producing biopharmaceuticals, and specializes in single-use bags & containers, cell cultivation, fermentation, and filtration. It has a presence in over 60 locations globally, with headquarters in Goettingen, Germany.

One of its key products, Celsius® CFT, is a technology that regulates the thawing and freezing rate to reduce cryo-concentration in biopharmaceutical products.

Report Synopsis:

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.